Fig. 5From: Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancerRelative proportion of immune infiltration in high-risk and low-risk groups. A GO analysis of DEGs. B KEGG pathway analysis of DEGs. C The immune microenvironment among the two risk groups. D Heatmap of immune cell differences between two subgroups. E Immune cells the between two subgroups. F Gene expression of HLA gene sets between two distinct clustersBack to article page